Surgery Partners (SGRY) Expected to Announce Quarterly Earnings on Monday

Surgery Partners (NASDAQ:SGRY) is projected to issue its Q4 2025 results after the market closes on Monday, March 2nd. Analysts expect the company to announce earnings of $0.31 per share and revenue of $866.5440 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Tuesday, March 3, 2026 at 8:30 AM ET.

Surgery Partners Stock Up 0.8%

SGRY stock opened at $15.50 on Friday. The stock has a market capitalization of $2.00 billion, a PE ratio of -11.40 and a beta of 1.97. Surgery Partners has a 52 week low of $13.14 and a 52 week high of $25.05. The company has a quick ratio of 1.72, a current ratio of 1.88 and a debt-to-equity ratio of 1.10. The firm has a 50 day moving average of $15.34 and a 200 day moving average of $18.44.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SGRY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Surgery Partners by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 45,693 shares of the company’s stock worth $1,085,000 after purchasing an additional 2,015 shares in the last quarter. Millennium Management LLC increased its holdings in Surgery Partners by 1,253.7% in the first quarter. Millennium Management LLC now owns 202,274 shares of the company’s stock valued at $4,804,000 after buying an additional 219,806 shares in the last quarter. Empowered Funds LLC increased its holdings in Surgery Partners by 11.0% in the first quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock valued at $305,000 after buying an additional 1,278 shares in the last quarter. Prudential Financial Inc. acquired a new position in shares of Surgery Partners in the second quarter worth about $219,000. Finally, Invesco Ltd. boosted its stake in shares of Surgery Partners by 7.4% during the 2nd quarter. Invesco Ltd. now owns 1,683,311 shares of the company’s stock worth $37,420,000 after acquiring an additional 115,627 shares in the last quarter.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on SGRY. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a report on Monday, November 24th. Royal Bank Of Canada dropped their price target on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 11th. Benchmark reduced their price objective on Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a research note on Tuesday, November 11th. Mizuho decreased their target price on Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Thursday, December 18th. Finally, Barclays cut their price target on shares of Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday, November 21st. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $27.11.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.